Does DOXORUBICIN Cause Product use in unapproved indication? 3,502 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,502 reports of Product use in unapproved indication have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 4.2% of all adverse event reports for DOXORUBICIN.
3,502
Reports of Product use in unapproved indication with DOXORUBICIN
4.2%
of all DOXORUBICIN reports
821
Deaths
978
Hospitalizations
How Dangerous Is Product use in unapproved indication From DOXORUBICIN?
Of the 3,502 reports, 821 (23.4%) resulted in death, 978 (27.9%) required hospitalization, and 339 (9.7%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 3,502 reports have been filed with the FAERS database.
What Other Side Effects Does DOXORUBICIN Cause?
Febrile neutropenia (8,844)
Off label use (7,858)
Disease progression (6,165)
Neutropenia (5,891)
Drug ineffective (4,598)
Pyrexia (3,697)
Thrombocytopenia (3,638)
Anaemia (3,601)
Nausea (2,925)
Sepsis (2,740)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which DOXORUBICIN Alternatives Have Lower Product use in unapproved indication Risk?
DOXORUBICIN vs DOXYCYCLINE
DOXORUBICIN vs DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYLAMINE
DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE